Thomas R. Cox, Apr 2017
ROCK-ing pancreatic cancer to the core
Our new paper on short-term pulsed treatment, or ‘priming’ as a treatment strategy to boost chemotherapy has just been published in Science Translational Medicine.
STM Front Cover Vol 9 Issue 384 (Image: Timpson Laboratory, Garvan Institute)
The research, spearheaded by Dr. Paul Timpson and Dr. Marina Pajic here at the Garvan Institute of Medical Research in Sydney, has uncovered a promising new approach to treating pancreatic cancer. By targeting the tissue surrounding the tumour to make it ‘softer’, it leads to tumours being more responsive to chemotherapy.
